Position in GILD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,180,920
+$745,871 QoQ
Shares Held
44,349
+0.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MAI Capital Management holds $463,973,037 across 18 Drug Manufacturers - General names. GILD ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
548,990 | $134,195,115 | |
| 2 | ABBV |
AbbVie Inc.
|
577,833 | $125,672,899 | |
| 3 | LLY |
ELI LILLY & Co
|
96,089 | $88,379,779 | |
| 4 | MRK |
Merck & Co., Inc.
|
335,023 | $40,299,916 | |
| 5 | AMGN |
Amgen Inc
|
87,280 | $30,709,468 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
223,761 | $13,571,104 | |
| 7 | PFE |
Pfizer Inc
|
420,692 | $11,813,031 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
44,349 | $6,180,920 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,180,920 | 44,349 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,435,049 | 44,281 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,696,854 | 42,314 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,178,088 | 28,665 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $2,858,731 | 25,513 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,429,515 | 26,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,049,049 | 24,440 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,962,314 | 28,601 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,427,431 | 33,139 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $2,851,470 | 35,199 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,727,141 | 36,391 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,634,483 | 34,183 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,371,071 | 40,630 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $2,890,483 | 33,669 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,420,597 | 23,028 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $892,289 | 14,436 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $590,992 | 9,941 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $547,406 | 7,539 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $395,909 | 5,668 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $312,417 | 4,537 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $435,670 | 6,741 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $453,146 | 7,778 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $738,627 | 11,689 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,822,246 | 23,684 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $1,482,191 | 19,826 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||